Therapeutic treatment methods for humans or animals are excluded from patentability under most legal systems around the world, and Mexican law is no exception. Article 19(VII) of the Industrial Property Law excludes such methods from patentability because they are not considered inventions.
However, it is generally feasible to obtain patent protection in Mexico if method claims are amended to a “Swiss-type” format - for example, “the use of a substance X for the manufacture of a medicament for the treatment of disease Y, according to an article by Jasmin Maqueda of law firm Becerril, Coca & Becerril, posted on the International Law Office web site
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze